Identification
Personal identification
- Full name
- Teresa Sousa
Citation names
- Sousa, Teresa
Author identifiers
- Ciência ID
- 5C11-68F9-76AD
- ORCID iD
- 0000-0001-7230-5020
- Scopus Author Id
- 6603380101
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
- Medical and Health Sciences - Basic Medicine - Neurosciences
- Medical and Health Sciences - Clinical Medicine - Cardiac and Cardiovascular Systems
- Medical and Health Sciences - Clinical Medicine - Paediatrics
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | |||||
French |
Education
Degree | Classification | |
---|---|---|
2006/05/05
Concluded
|
Farmacologia (Doutoramento)
Major in Sem especialidade
Universidade do Porto Faculdade de Farmácia, Portugal
"A Hipertensão Causada por um Bloqueador dos Receptores da Adenosina. Papel do Stress Oxidativo/ Hypertension induced by an
antagonist of adenosine receptors. Role of oxidative stress." (THESIS/DISSERTATION)
|
Approved by unanimity |
1999/07/13
Concluded
|
Ciências Farmacêuticas (Licenciatura)
Major in Não Aplicável
Universidade do Porto Faculdade de Farmácia, Portugal
|
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2020/09/01 - Current | Auxiliary Researcher (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2014 - Current | Researcher (Research) | Universidade do Porto Centro de Investigação Farmacológica e Inovação Medicamentosa, Portugal |
Universidade do Porto Centro de Investigação Farmacológica e Inovação Medicamentosa, Portugal | ||
2019/01/01 - 2020/08/31 | Contracted Researcher (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2015/10/01 - 2018/12/31 | Postdoc (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2009/07/01 - 2014/06/30 | Contracted Researcher (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2006/06/01 - 2009/06/30 | Postdoc (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2002/01/01 - 2006/05/05 | Researcher (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal (...) |
||
2000/01/01 - 2001/12/31 | Research Trainee (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
1999/01 - 1999/12 | Research Trainee (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2020/02/10 - Current | Lecturer (University Teacher) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2017/09/01 - 2020/02/09 | Invited Assistant Professor (University Teacher) | Universidade do Porto Faculdade de Medicina, Portugal |
2015/09/30 - 2017/08/31 | Invited Assistant Professor (University Teacher) | Universidade do Porto Faculdade de Medicina, Portugal |
2008/10/27 - 2015/09/13 | Tutor (University Teacher) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal | ||
2006/10/17 - 2012/10/06 | Invited Assistant (University Teacher) | Universidade do Porto Faculdade de Farmácia, Portugal |
2002 - 2004 | Invited Assistant (University Teacher) | Instituto Universitário de Ciências da Saúde, Portugal |
Instituto Universitário de Ciências da Saúde, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2015 - 2018 | Resolving inflammation in heart failure: lipoxins as new therapeutic targets.
SFRH/BPD/112005/2015
Post-doc Fellow
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2006 - 2009 | Role of angiotensin II-induced oxidative stress in the pathogenesis of arterial hypertension.
SFRH/BPD/21863/2005
Post-doc Fellow
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2002 - 2006 | Hypertension induced by an antagonist of adenosine receptors. Role of oxidative stress.
SFRH/BD/7055/2001
PhD Student Fellow
Universidade do Porto Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Contract
Designation | Funders | |
---|---|---|
2018/07/15 - 2022/07/14 | Resolution of inflammation: a missing key to improve acute heart failure treatment and prognosis?
PTDC/MEC-CAR/32188/2017
POCI-01-0145-FEDER- 032188
Principal investigator
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia European Regional Development Fund Concluded
|
2020/07/09 - 2021/07/08 | Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and
therapeutic targets
613690173
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2014/04 - 2015/08 | RES4MED: learning medicine through research
EXPL/IVC-PEC/1302/2013
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2013/05 - 2015/04 | Childhood obesity-related inflammation and vascular injury - Impact on the kidney
PTDC/DTP-PIC/0239/2012
Researcher
Universidade do Porto Instituto de Saúde Pública, Portugal
|
Fundação para a Ciência e a Tecnologia European Regional Development Fund Concluded
|
2011/04 - 2014/09 | Interaction of aspirin with antihypertensive drugs - impact on renal oxidative stress, inflammation, local renin-angiotensin
system activation and blood pressure control
PTDC/SAU-TOX/114166/2009
Principal investigator
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia European Regional Development Fund Concluded
|
2009 - 2010 | Evaluation of intrarenal renin-angiotensin system activation and oxidative stress in chronic heart failure.
PP-IJUP2009-119
Principal investigator
Universidade do Porto Faculdade de Medicina, Portugal
|
Universidade do Porto Banco Santander Totta Concluded
|
2000/01/01 - 2001/12/31 | Crosstalk between bradykinin and an unknown agent (angiotensin II?) on the endothelial control of heart function and arterial
vasomotricity
Praxis/C/SAU/14294/1998
Research Fellow
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Other
Designation | Funders | |
---|---|---|
2019 - 2020 | Redox dysfunction as a therapeutic target in neuropathic pain: specific inhibition of NADPH oxidase isoform 2 (NOX2)
s/ref
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
Universidade do Porto Centro de Investigação Farmacológica e Inovação Medicamentosa, Portugal |
Fundação Grünenthal
Concluded
|
2018 - 2019 | Oxidative dysfunction and neuroinflammation as targets in neuropathic pain: mediators of pro-resolving inflammation.
s/ref
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação Grünenthal
Concluded
|
2002 - 2003 | Role of renin-angiotensin system activation in vascular redox dysfunction.
s/ref
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação Calouste Gulbenkian
Concluded
|
Outputs
Publications
Book chapter |
|
Conference abstract |
|
Conference paper |
|
Conference poster |
|
Journal article |
|
Newsletter article |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/02/08 | ACE and ACE2 activities in the feces of patients with inflammatory bowel disease on biological treatment | 54th Meeting of the Portuguese Society of Pharmacology
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2024/02/08 | Resolvin E1 is a major mediator of the inflammatory response in hospitalized COVID-19 patients | 54th Meeting of the Portuguese Society of Pharmacology
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2023/09/25 | Renin-angiotensin-aldosterone system in acute heart failure and cardiogenic shock. | Seminar "Renin-angiotensin-aldosterone system in health and disease: new insights into a classic system."
Faculdade de Farmácia da Universidade do Porto (Portugal)
|
2023/09/25 | Impact of hypertension and previous treatment with RAAS inhibitors in endothelial dysfunction in hospitalized COVID-19 patients. | Seminar "Renin-angiotensin-aldosterone system in health and disease: new insights into a classic system."
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
|
2023/09/25 | Activity of angiotensin-converting enzymes (ACE and ACE2) in patients with COVID-19 of different severity. | Seminar "Renin-angiotensin-aldosterone system in health and disease: new insights into a classic system."
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
|
2023/09/25 | ACE/ACE2 balance in the healthy and inflamed gut | Seminar "Renin-angiotensin-aldosterone system in health and disease: new insights into a classic system."
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
|
2023/09 | Endothelial dysfunction in different stages of disease severity of COVID-19: focus on endocan and arterial hypertension. | 18th YES Meeting 2023
(Porto, Portugal)
|
2023/02 | Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients | LIII Reunião Anual da Sociedade Portuguesa de Farmacologia
(Coimbra, Portugal)
|
2023/02 | Oxidative stress association with COVID-19 severity and mortality: focus on urinary isoprostanes | LIII Reunião Anual da Sociedade Portuguesa de Farmacologia
(Coimbra, Portugal)
|
2023/02 | Endothelial dysfunction in different stages of COVID-19 severity. | LIII Reunião Anual da Sociedade Portuguesa de Farmacologia
(Coimbra, Portugal)
|
2022/06 | Resolution of inflammation versus proinflammatory status in human acute heart failure and cardiogenic shock | 15th World Congress on Inflammation (WCI2022)
(Rome, Italy)
|
2022/05/17 | Unresolved inflammation and endothelitis in severe and critically ill COVID-19 | EUGLOHRIA Seeding Conference
EUGLOHRIA
|
2022/02/11 | Effects of NADPH oxidase isoform-2 inhibition on behavioral responses and neuroinflammatory markers in a mouse model of neuropathic pain. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (SPF) (Portugal)
|
2022/02/11 | ACE2 in experimental colitis. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (SPF) (Portugal)
|
2022/02/11 | ACE2/ACE balance in COVID-19 patients with different disease severity. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (SPF) (Portugal)
|
2022/02/09 | Inflammatory cytokine response in moderate and severe COVID-19 patients and its relationship to prognosis. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (SPF) (Portugal)
|
2022/02/09 | Arachidonic acid derived proresolving or proinflammatory mediators and lipoxin receptor expression in human acute heart failure and cardiogenic shock | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (SPF) (Portugal)
|
2022/02/09 | Impact of previous ß-blocker treatment on inflammatory status of acute heart failure and cardiogenic shock patients. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (SPF) (Portugal)
|
2021/12/08 | Comparison of endothelial activation profiles in critically ill patients with cardiogenic shock, septic shock and severe COVID-19. | 8th European Virtual Congress of Pharmacology (EPHAR 2021)
EPHAR (Czech Republic)
|
2021/12/08 | Inflammatory and resolution of inflammation responses in critically ill patients with cardiogenic shock, septic shock and severe COVID-19. | 8th European Virtual Congress of Pharmacology (EPHAR 2021)
EPHAR (Czech Republic)
|
2021/12/08 | Evaluation of serum and urinary lipoxin profiles and FPR2/ALX receptor expression in human acute heart failure, cardiogenic shock and septic shock. | 8th European Virtual Congress of Pharmacology (EPHAR 2021)
EPHAR (Czech Republic)
|
2021/05 | Endocan - a potential new biomarker of inflammation-driven "endothelitis" in human acute heart failure and cardiogenic shock. | Congresso Português de Cardiologia 2021 (CPC 2021)
(Portugal)
|
2021/02/19 | Urinary biomarkers of oxidative stress, inflammation and vascular dysfunction in septic shock patients and their relationship with organ dysfunction and prognosis. | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Portugal)
|
2021/02/18 | Endothelial cell activation and proinflammatory status decrease during hospitalization in septic shock but not in cardiogenic shock. | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Portugal)
|
2021/02/18 | Behavioral responses in a mouse model of neuropathic pain after systemic inhibition of NADPH oxidase isoform-2 (Nox2). | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Portugal)
|
2021/02/17 | Resolution of inflammation in human acute heart failure and cardiogenic shock: role of resolvin D1 and E1. | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia
|
2020/09 | Lipoxin profiles in human acute heart failure and cardiogenic shock and their modulation by aspirin or statin therapy. | ESCI Virtual - COVID Edition 2020 |
2020/09 | Proinflammatory cytokines and endothelial cell activation in human acute heart failure and cardiogenic shock. | ESCI Virtual - COVID Edition 2020 |
2020/02 | Serum and urinary lipoxins profiles in patients with acute heart failure and cardiogenic shock. | L Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2020/02 | Comparison of the inflammatory profile in patients with cardiogenic shock or septic shock. | L Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2019/09 | Endocan, a novel endothelial dysfunction biomarker, is associated with ventricular dysfunction, inflammation and worse hemodynamics in human acute heart failure. | YES Meeting 2019
Universidade do Porto Faculdade de Medicina (Porto, Portugal)
|
2019 | Endothelial dysfunction and inflammation resolving mediators in human acute heart failure. | XLIX Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2019 | Specialized proresolving mediators (SPMs) in human acute heart failure (AHF). | 1ª Reunião do Programa Doutoral em Farmacologia e Toxicologia Experimental e Clínica
Universidade do Porto Faculdade de Medicina (Porto, Portugal)
|
2018 | Endocan and resolvin D1: two novel biomarkers for the management of acute heart failure? | 31st Annual Congress of the European Society of Intensive Care Medicine – ESICM LIVES 2018
European Society of Intensive Care Medicine (Paris, France)
|
2016 | The attenuation of the hypertensive effect of angiotensin II by L-proline is probably linked to its ability to decrease asymmetric dimethylarginine. | XLVI Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2015 | L-proline supplementation attenuates the development of arterial hypertension induced by angiotensin II. | XLV Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2014/06 | Low-dose aspirin improves renal function and antihypertensive efficacy in hypertensive rats treated with losartan. | 3rd International Conference on Nephrology & Therapeutics
OMICS International (Valencia, Spain)
|
2013 | Anti-inflammatory lipoxins in patients with chronic heart failure and their modulation by low-dose acetylsalicylic acid. | 47th Annual Scientific Meeting of the European Society for Clinical Investigation
European Society for Clinical Investigation (Albufeira, Portugal)
|
2013 | Anti-inflammatory lipid mediators in cardiovascular diseases: impact of aspirin. | Seminários FMUP
Universidade do Porto Faculdade de Medicina (Porto, Portugal)
|
2012 | Hydrogen peroxide regulates renal production of renin and angiotensinogen in angiotensin II-hypertensive rats. | XLII Reunião da Sociedade Portuguesa de Farmacologia
Reunião da Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2011 | Polyethylene glycol catalase reduces the renal medullary expression of Nox4 and AT1 receptor but markedly increases systemic angiotensinogen levels in angiotensin II-infused rats. | 21st European Meeting on Hypertension and Cardiovascular Prevention
European Society of Hypertension (Milan, Italy)
|
2011 | Counterregulatory mechanisms involved in the blunted antihypertensive response to polyethyleneglycol catalase in angiotensin II-infused rats. | XLI Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2010 | Lack of sustained antihypertensive effect of polyethylene glycol catalase treatment in angiotensin II-hypertensive rats. | 20th European Meeting on Hypertension
European Society of Hypertension (Oslo, Norway)
|
2010 | Oxidative stress and disease. | VI Dia de Biologia Marinha e Biotecnologia
Escola Superior de Turismo e Tecnologia do Mar, Instituto Politécnico de Leiria (Peniche, Portugal)
|
2009 | The renal medulla is a major target for redox dysfunction and altered nuclear signalling in angiotensin II (Ang II)-dependent hypertension. | 19th European Meeting on Hypertension
European Society of Hypertension (Milan, Italy)
|
2009 | A hipertensão arterial causada pela angiotensina II está associada a um aumento da produção de H2O2 e a alterações da sinalização celular na medula renal. | 3º Congresso Português de Hipertensão
Sociedade Portuguesa de Hipertensão (Vilamoura, Portugal)
|
2009 | Short-term antihypertensive effectiveness of polyethylene glycol catalase treatment in angiotensin II-hypertensive rats. | XL Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2008 | Increased H2O2 production in the renal medulla of angiotensin II-hypertensive rats, through a NADPH oxidase mediated pathway. | XXXIX Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2007 | Produção de peróxido de hidrogénio (H2O2) em dois modelos de hipertensão arterial com aumento da angiotensina II. | 1º Congresso Português de Hipertensão
Sociedade Portuguesa de Hipertensão (Vilamoura, Portugal)
|
2007 | Apocynin, but not tempol, prevents the rise in vascular and urinary levels of H2O2 induced by chronic infusion of 1,3-dipropyl-8-sulfophenylxanthine (DPSPX). | XXXVIII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2006 | Vascular and systemic redox dysfunction in hypertension due to blockade of adenosine receptors. | Xth Workshop of the ESH Young Investigator Initiative Group, 16th European Meeting of Hypertension
European Society of Hypertension (Madrid, Spain)
|
2005 | Apocynin, but not tempol, attenuates the hypertension and increases vascular antioxidant defenses in rats with activation of the renin-angiotensin system. | Young Investigators Initiative, 15th European Meeting of Hypertension
European Society of Hypertension (Milan, Italy)
|
2005 | Increased oxidative stress in a model of hypertension with activation of the renin-angiotensin system. | XXXVI Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2005 | NADPH oxidase and hydrogen peroxide mediate vascular hyperplasia and hypertension in rats with activation of the renin-angiotensin system. | XXXVI Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2004 | Antioxidant enzyme activity in resistance and conduit vessels from hypertensive rats with activation of the renin-angiotensin system. | EPHAR 2004
EPHAR/Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2003 | Vascular antioxidant enzyme activity in renovascular hypertensive rats. | Young Investigators Initiative, 13th European Meeting on Hypertension
European Society of Hypertension (Milan, Italy)
|
2003 | Comparison of vascular glutathione peroxidase activity in 1,3-dipropyl-8-sulphophenylxanthine hypertensive rats and in renovascular hypertension. | 11th Porto Meeting on Adrenergic Mechanisms
Universidade do Porto Faculdade de Medicina (Porto, Portugal)
|
2003 | Papel da activação do sistema renina-angiotensina na disfunção redox vascular. [Apresentação do projecto premiado. ] | Prémio Jovem Investigador – Programa Gulbenkian de Estímulo à Investigação 2002
Fundação Calouste Gulbenkian (Lisboa, Portugal)
|
2003 | Actividade antioxidante na artéria mesentérica e na aorta num modelo de hipertensão com activação do sistema renina-angiotensina. | IX Reunião da Associação Portuguesa de Hipertensão
Associação Portuguesa de Hipertensão (Sintra, Portugal)
|
2003 | Comparison of antioxidant enzyme activity in arteries and veins from renovascular hypertensive rats. | XXXIV Reunião da Sociedade Portuguesa de Farmacologia
Reunião da Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2002 | Estudo do efeito de alguns derivados xantínicos sobre o monóxido de azoto. | VIII Reunião da Associação Portuguesa de Hipertensão
Associação Portuguesa de Hipertensão (Vidago, Portugal)
|
2002 | Vascular antioxidant enzyme activity in hypertension caused by blockade of adenosine receptors. | XXXIII Reunião da Sociedade Portuguesa de Farmacologia
Reunião da Sociedade Portuguesa de Farmacologia. (Lisboa, Portugal)
|
2001 | Prevention of 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension by losartan and atenolol. | Fifth WorkShop of the Young Investigator Initiative Group, Eleventh European Meeting on Hypertension
European Society of Hypertension (Milan, Italy)
|
2001 | Scavenging effect of DPSPX (1,3-dipropyl-8-sulfophenylxanthine) on nitric oxide. | XXXII Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2000 | Effects of losartan and atenolol in DPSPX (1,3-dipropyl-8-sulfophenylxanthine)-induced hypertension. | 10th Porto Meeting on Adrenergic Mechanisms
Universidade do Porto Faculdade de Medicina (Porto, Portugal)
|
2000 | Antihypertensive effects of losartan and atenolol in 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-induced hypertension. | XXXI Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
1999 | Radiofármacos - Características e Boas Práticas de Manipulação. | 2as Jornadas Transmontanas de Farmácia
2as Jornadas Transmontanas de Farmácia (Chaves, Portugal)
|
1999 | Losartan prevents 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-induced hypertension. | XXX Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2020/10/01 - Current | Adrenergic regulation of resolution of inflammation and endothelial function in human acute heart failure and cardiogenic
shock
Supervisor of Carolina Isabel Ribeiro da Silva Pereira
|
Programa Doutoral em Farmacologia e Toxicologia Experimental e Clínicas (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2016 - Current | Resolution of inflammation in acute heart failure.
Co-supervisor of Marta Fernanda Reina Couto
|
Programa Doutoral em Farmacologia e Toxicologia Experimentais e Clínicas (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/09/01 - 2022/07/01 | Evaluation of urinary 11-dehydrothromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart
failure.
Supervisor of Ana Isabel Sousa Oliveira
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/09/01 - 2022/06/17 | Evolution of endocan and other endothelial dysfunction markers in COVID-19 patients with different stages of disease severity.
Supervisor of David André Rosário Alves
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/09/01 - 2022/05/26 | Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients.
Supervisor of Mariana Simões de Carvalho Roboredo Madeira
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020/09/01 - 2021/06/22 | Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship
with organ dysfunction in human septic shock.
Supervisor of Marisa Oliveira Santos
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020/09/01 - 2021/05/28 | Renal renin-angiotensin system activation in acute heart failure and its association with endothelial dysfunction, inflammation
and oxidative stress.
Supervisor of Álvaro Alexandre Ferreira Duarte
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2019/08 - 2020/08 | Endocan: a novel biomarker for risk stratification, prognosis, and therapeutic monitoring in human cardiovascular and renal
diseases.
Supervisor of João Pedro Peixoto de Bessa e Silva
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2018 - 2019 | Gender-related differences in cardiometabolic risk factors and oxidative stress among prepubertal children with obesity
Co-supervisor of Nelson André Oliveira Godinho
|
Mestrado Integrado em Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2016 - 2017 | Aspirin and blood pressure: effects when used alone or in combination with antihypertensive drugs.
Supervisor of Ana Catarina Gonçalves da Costa
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2014 - 2015 | Statins and oxidative stress in chronic heart failure.
Co-supervisor of Sónia Cristina Torres da Costa
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2013 - 2014/07 | Role of semicarbazide-sensitive amine oxidases (SSAO) in the regulation of blood pressure and vascular and renal oxidative
stress.
Supervisor of Sofia de Magalhães Lima e Oliveira de Freitas
|
Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2013 - 2014 | Resolution of inflammation in heart failure: novel lipid mediators.
Supervisor of Luís Manuel Pedrosa do Vale
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2013 - 2014 | Effect of proline supplementation on the development of arterial hypertension and on the production and elimination of hydrogen
peroxide - studies in angiotensin II-treated rats
Supervisor of Joana dos Santos Pinto Martins Leal
|
Toxicologia Analítica Clínica e Forense (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2012 - 2013 | Interaction of aspirin with losartan: impact on inflammation, oxidative stress and lipoxin production in an experimental model
of arterial hypertension.
Supervisor of Liliana Raquel Ferraz de Almeida
|
Licenciatura em Bioquímica (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
|
2011/09 - 2012/07 | Evaluation of lipoxins in heart failure.
Supervisor of Jorge Daniel Moreira da Silva de Carvalho
|
Mestrado em Bioquímica (Master)
Universidade do Porto Faculdade de Ciências, Portugal
|
2011 - 2012/06 | Oxidative stress in heart failure: therapeutic implications.
Co-supervisor of Marco Frederico Oliveira Marques
|
Mestrado Integrado em Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2010 - 2011 | Evaluation of NADPH oxidases expression in heart failure.
Supervisor of Isabel Helena da Silva Ribeiro
|
Licenciatura em Bioquímica (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2016 - 2016 | Member of the Organising Committee of XLVI Reunião da Sociedade Portuguesa de Farmacologia, 2016, FMUP, Porto, Portugal.
(2016 - 2016)
Congress (Member of the Organising Committee)
|
Universidade do Porto Faculdade de Medicina, Portugal |
1997 - 1997 | Member of the Organising Committee of the Congress Depressão e antidepressivos - Uma questão de nervos, 1997, Seminário de
Vilar, Porto, Portugal. (1997 - 1997)
Congress (Member of the Organising Committee)
|
Universidade do Porto Faculdade de Farmácia, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2023/09/25 - 2023/09/25 | Chair, Seminar "Renin-angiotensin-aldosterone system in health and disease: new insights into a classic system"
Seminar
|
Seminar "Renin-angiotensin-aldosterone system in health and disease: new insights into a classic system"
Universidade do Porto Faculdade de Farmácia, Portugal
|
2023/04 - 2023/04 | Science communication - Presentation entitled: ""Medical doctor scientists @FMUP: the experience of medical students in the
research of new therapeutic targets in cardiovascular and infectious diseases"
Exhibition
|
20ª Mostra da Universidade do Porto
Universidade do Porto, Portugal
|
2023/02 - 2023/02 | Chair, Session 19 - Cardiovascular Pharmacology, LIII Meeting of the Portuguese Society of Pharmacology
Congress
|
Sociedade Portuguesa de Farmacologia, Portugal
|
2022/02 - 2022/02 | Chair, Session 4 - Cardiovascular Pharmacology, LII Meeting of the Portuguese Society of Pharmacology
Congress
|
LII Meeting of the Portuguese Society of Pharmacology
Sociedade Portuguesa de Farmacologia, Portugal
|
2021/02 - 2021/02 | Chair, Session Clinical Pharmacology III, LI Meeting of the Portuguese Society of Pharmacology
Congress
|
Sociedade Portuguesa de Farmacologia, Portugal
|
2016/05 - 2016/05 | Speaker, Round Table: "Evaluation of the Doctoral Programmes of the Faculty of Medicine, University of Porto (FMUP)", 5th
Meeting of PhD Students from FMUP
Meeting
|
5th Meeting of PhD Students from FMUP
Universidade do Porto Faculdade de Medicina, Portugal
|
2016/02 - 2016/02 | Chair, Session 8 - Endocrine Pharmacology, XLVI Meeting of the Portuguese Society of Pharmacology
Congress
|
Sociedade Portuguesa de Farmacologia, Portugal
|
2011/02 - 2011/02 | Chair, Toxicology Session, XLI Meeting of the Portuguese Society of Pharmacology
Congress
|
Sociedade Portuguesa de Farmacologia, Portugal
|
2010/09 - 2010/09 | Chair, 3rd Panel, 6th Edition of the School of Life and Health Sciences (ECVS), Junior University, University of Porto
Congress
|
Universidade do Porto, Portugal
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2023/10/09 | Efficacy of Deep Brain Stimulation (DBS) for the Treatment of Dystonia in Cerebral Palsy Patients - A Metanalysis.
(Thesis) Arguer
|
Nicole Pedroarena Leal (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2023/03/24 | Hydroxytyrosol and hypertension associated with chronic intermittent hypoxia: impact and contribution of AhR alternative pathway
(Thesis) Main arguer
|
Maria João Andrade Correia (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2021/05/25 | Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure - a review.
President of the jury
|
Diogo Antunes da Silva Marques (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/05/13 | Improving Medication Adherence In Hypertensive Patients: A Scoping Review.
President of the jury
|
Simão Alves Pinho (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020/05/25 | O papel da reserva cognitiva na infeção pelo VIH.
President of the jury
|
Ana Isabel Pestana Lopes (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020/05/25 | FGF23 effects within the vasculature: more insights into Atherosclerosis?
President of the jury
|
Maria Inês Coelho Fernandes (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2019/12 | Estrategias de tratamiento del paciente com insuficiencia cardiaca sistólica agudamente descompensada: Efectos de frequentes
dosis de furosemida sobre los noveles séricos de urea y sobre el cociente urea/creatinina.
(Thesis) Arguer
|
Rafael Ramón Villegas Mendez (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2019/03/08 | Investigating the role of the mercapturate pathway in kidney function for the identification of an early indicator tubular
dysfunction
(Thesis) Main arguer
|
CLARA LÚCIA GONÇALVES DIAS (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2019 | Effect of tetrahydrocannabinol on COMT activity in mice prefrontal cortex
(Thesis) Main arguer
|
Ana Catarina Relvas do Novo (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2012 | Aliscireno: Farmacologia e Interesse Terapêutico.
(Thesis) Main arguer
|
Bruno Filipe Leite Pinheiro (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2011/05 | The effect of oxidative stress in the intestinal absorption of folic acid: in vitro studies with Caco-2 cells.
(Thesis) Main arguer
|
Mafalda Raquel dos Santos Couto (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2011 | Osteoporose - Bifosfonatos.
(Thesis) Main arguer
|
Paula Joana Fernandes Gomes (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2011 | Vitamina D: o lado mais benéfico da exposição à radiação UV.
(Thesis) Main arguer
|
Cláudia Fernandes Domingues (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2011 | Utilização de bifosfonatos no tratamento da osteoporose pós-menopáusica.
(Thesis) Main arguer
|
Carla Sofia Fernandes Correia (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2011 | Fatores de risco cardiovascular: Hipertensão Arterial.
(Thesis) Main arguer
|
Tânia Isabel Gonçalves Matos (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2011 | Perturbação de Hiperatividade com Défice de Atenção.
(Thesis) Main arguer
|
Magali Correia do Lago (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 | Asma: Intervenção Farmacêutica.
(Thesis) Main arguer
|
Cristina Magalhães Dias (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 | Tratamento da artrite reumatóide em adultos.
(Thesis) Main arguer
|
Sandra Maria Pinto de Brito Novo (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
Ad Hoc journal article review
Journal title (ISSN) | Publisher | |
---|---|---|
2024/05 - 2024/09 | Frontiers in Immunology (1664-3224 (Online)) | FRONTIERS MEDIA SA |
2023 - 2023 | Frontiers in Nutrition (2296-861X) | FRONTIERS MEDIA SA |
2021 - 2021 | Frontiers in Pharmacology | FRONTIERS MEDIA SA |
2018 - 2021 | Life Sciences (0024-3205) | PERGAMON-ELSEVIER SCIENCE LTD |
2019 - 2019 | Nitric Oxide-Biology and Chemistry (1089-8603) | ACADEMIC PRESS INC ELSEVIER SCIENCE |
2019 - 2019 | Acta Reumatologica Portuguesa (0303-464X) | PUBLISAUDE-EDICOES MEDICAS LDA |
2016 - 2019 | Cardiology Journal (1897-5593) | VIA MEDICA |
2018 - 2018 | Pediatric Nephrology (0931-041X) | SPRINGER |
2016 - 2016 | PeerJ (2167-8359) | PEERJ INC |
2013 - 2013 | International Journal of Nanomedicine (1178-2013) | DOVE MEDICAL PRESS LTD |
2007 - 2008 | Journal of Enzyme Inhibition and Medicinal Chemistry (1475-6366) | TAYLOR & FRANCIS LTD |
Association member
Society Organization name | Role | |
---|---|---|
2022/05 - Current | Ordem dos Farmacêuticos | Member |
2002 - Current | Sociedade Portuguesa de Farmacologia | Effective Member |
2000 - Current | Sociedade Portuguesa de Neurociências | Effective Member |
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2017/02 - 2019/02 | Secretary of the General Assembly of the Portuguese Society of Pharmacology
Other
|
Sociedade Portuguesa de Farmacologia, Portugal |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2021/09/01 - Current | Neuronal Excitability and Neurotransmission [Module Director] | Neurobiologia | Universidade do Porto Faculdade de Medicina, Portugal |
2021/09 - Current | Pharmacology of Synaptic Transmission [Module Director] | Neurociências | Universidade do Porto Faculdade de Medicina, Portugal |
2021/05 - Current | Redox state: diet, metabolic regulation and aging. "Oxidative stress: implications for blood pressure". | Metabolismo ¿ Biopatologia e Experimentação | Universidade do Porto Faculdade de Medicina, Portugal |
2020/02 - Current | Methods in Neurosciences: Pharmacological approaches. | Neurociências | Universidade do Porto Faculdade de Medicina, Portugal |
2020/02 - Current | In vivo methods in Pharmacology: "Animal models of cardiovascular disease" | Farmacologia e Toxicologia Experimentais e Clínicas | Universidade do Porto Faculdade de Medicina, Portugal |
2019 - Current | Neuronal Excitability and Neurotransmission: "General Pharmacology I: Pharmacodynamics and general mechanisms of drug action. Types of receptors: GPCRs and signalling pathways." | Neurobiologia (Mestrado) | Universidade do Porto Faculdade de Medicina, Portugal |
2017 - Current | Pharmacology of Synaptic Transmission: "Neurotransmission and neuromodulation. Adrenergic transmission." | Neurociências (Doutoramento) | Universidade do Porto Faculdade de Medicina, Portugal |
2017 - Current | Neuronal Excitability and Neuromodulation: "Neurotransmission and neuromodulation. Adrenergic transmission." | Neurobiologia (Mestrado integrado) | Universidade do Porto Faculdade de Medicina, Portugal |
2015 - Current | In vivo methods in Pharmacology: "Animal models of cardiovascular disease" | Farmacologia e Toxicologia Experimentais e Clínicas (Doutoramento) | Universidade do Porto Faculdade de Medicina, Portugal |
2013 - Current | Methods in Neurosciences: Pharmacological Approaches | Neurociências (Doutoramento) | Universidade do Porto Faculdade de Medicina, Portugal |
2010 - Current | Free Radicals, Oxidative stress and Antioxidants: Oxidative Stress and Arterial Hypertension. | Metabolismo - Clínica e Experimentação (Doutoramento) | Universidade do Porto Faculdade de Medicina, Portugal |
2008 - 2020 | Pharmacology I | Medicina (Mestrado integrado) | Universidade do Porto Faculdade de Medicina, Portugal |
2008 - 2020 | Pharmacology II | Medicina (Mestrado integrado) | Universidade do Porto Faculdade de Medicina, Portugal |
2012 - 2012 | Postgraduate Course in Pharmaceutical Care: Osteoporosis | Curso de pós-graduação em Cuidados Farmacêuticos (Pós-Graduação) | Ordem dos Farmaceuticos, Portugal |
2008 - 2012 | Pharmacology II | Ciências Farmacêuticas (Mestrado integrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
2010 - 2011 | Pharmacology I | Ciências Farmacêuticas (Mestrado integrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
2007 - 2008 | Pathophysiology and Pharmacotherapy I | Ciências Farmacêuticas (Mestrado integrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
2006 - 2007 | Pharmacology I | Ciências Farmacêuticas (Licenciatura) | Universidade do Porto Faculdade de Farmácia, Portugal |
2006 - 2007 | Pathophysiology and Pharmacotherapy II | Ciências Farmacêuticas (Licenciatura) | Universidade do Porto Faculdade de Farmácia, Portugal |
2003 - 2004 | Pharmacology | Ciências Farmacêuticas (Licenciatura) | Instituto Universitário de Ciências da Saúde, Portugal |
2002 - 2004 | Pharmacology | Medicina Dentária (Licenciatura) | Instituto Universitário de Ciências da Saúde, Portugal |
Evaluation committee
Activity description Role |
Institution / Organization | Funding entity | |
---|---|---|---|
2022/03/01 - 2022/03/31 | External Reviewer - Research Grant Proposal - Medical Research Council (MRC)-UK Research and Innovation (UKRI)
Evaluator
|
UK Research and Innovation, United Kingdom | UK Research and Innovation |
2015 - 2015 | External reviewer for the 2nd Call for Proposals of the International Fellowship Programme WHRI-ACADEMY (FP7 Marie Curie COFUND
scheme)
Evaluator
|
Barts and The London School of Medicine and Dentistry William Harvey Research Institute, United Kingdom | European Commission Seventh Framework Programme for Research and Technological Development People |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2023/07/03 - 2023/07/28 | IFMSA SCORE Research Exchange of International Medical Students - project: "Urinary hydrogen peroxide and its relation to the activity of proinflammatory/prooxidant or antioxidant enzyme activities in intensive care patients: focus on COVID-19 patients. | Vesna Bukovec |
2023/07/03 - 2023/07/28 | IFMSA SCORE Research Exchange of International Medical Students - project: "Urinary hydrogen peroxide and its relation to the activity of proinflammatory/prooxidant or antioxidant enzyme activities in intensive care patients: focus on COVID-19 patients. | Alifya Tarwandi |
2020/04 - 2022/06 | Doctorate Researcher - project RIFF-HEART (PTDC/MEC-CAR/32188/2017) | Patrícia Daniela Pereira Terra |
2021/08 - 2021/11 | Research fellowship (BI) - project RIFF-HEART (PTDC/MEC-CAR/32188/2017) | Luísa Alexandra Teixeira Santos |
2019/03 - 2020/09 | Research fellowship (BI) - project RIFF-HEART (PTDC/MEC-CAR/32188/2017) | Carolina Isabel Ribeiro Silva Pereira |
2019/06 - 2019/09 | Doctorate Researcher - project RIFF-HEART (PTDC/MEC-CAR/32188/2017) | Janete Maria Quelhas dos Santos |
2017 - 2018 | Project I - Urinary excretion of angiotensinogen and hydrogen peroxide in human acute heart failure | Rita Pereira Rodrigues da Cruz |
2013 - 2015 | Research Fellowship (BI) - project OBIKID (PTDC/DTP-PIC/0239/2012) | Dina Alexandra Cosme Figueiredo |
2012 - 2014 | Research fellowship (BI) - project: PTDC/SAU-TOX/114166/2009 | Jorge Daniel Moreira da Silva de Carvalho |
2011/04 - 2012 | Research fellowship (BI) - project: PTDC/SAU-TOX/114166/2009 | Maria João Portugal Couto Valente |
Other jury / evaluation
Activity description | Institution / Organization | |
---|---|---|
2023/05 - 2023/05 | Jury, Health Sciences Poster Session, IJUP 2023 (Meeting of Young Researchers of Universidade do Porto, 2023), Universidade do Porto, 2023 | Universidade do Porto, Portugal |
2022/09/12 - 2022/09/12 | Interview meeting - PhD Student: Mariana Ferreira Duarte - Project "Exploring The Ras-Independent Roles of ACE2 as New Biomarkers in Inflammatory Bowel Disease", Doctoral Programme in Experimental and Clinical Pharmacology and Toxicology | Universidade do Porto Faculdade de Medicina, Portugal |
2021/06 - 2021/06 | President of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the research project "Resolving inflammation: a key to improving the treatment and prognosis of acute heart failure? (RIFF-HEART)" (PTDC/MEC-CAR/32188/2017), funded by FEDER funds via COMPETE (Portugal 2020) and national funds by the FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2021/05/05 - 2021/05/07 | Jury, Health Sciences e-Poster Session, IJUP 2021 (Meeting of Young Researchers of Universidade do Porto, 2021), Virtual Session, Universidade do Porto, 2021 | Universidade do Porto, Portugal |
2019/12 - 2020/01 | President of the jury of the call for recruitment of a Doctorate Researcher within the scope of the research project "Resolving inflammation: a key to improving the treatment and prognosis of acute heart failure? (RIFF-HEART)" (PTDC/MEC-CAR/32188/2017), funded by FEDER funds via COMPETE (Portugal 2020) and national funds by the FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2019/03 - 2019/04 | President of the jury of the call for the recruiment of a Doctorate Researcher within the scope of the research project "Resolving inflammation: a key to improving the treatment and prognosis of acute heart failure? (RIFF-HEART)" (PTDC/MEC-CAR/32188/2017), funded by FEDER funds via COMPETE (Portugal 2020) and national funds by the FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2018/11 - 2019/02 | President of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the research project "Resolving inflammation: a key to improving the treatment and prognosis of acute heart failure? (RIFF-HEART)" (PTDC/MEC-CAR/32188/2017), funded by FEDER funds via COMPETE (Portugal 2020) and national funds by the FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2019 - 2019 | Jury, Poster session, IJUP 2019 (Meeting of Young Researchers of Universidade do Porto, 2019), Reitoria da Universidade do Porto, Porto, Portugal. | Universidade do Porto, Portugal |
2019 - 2019 | Jury, Poster session, 11th Symposium on Metabolism - Ageing & Metabolism, FMUP, Porto, Portugal. | Universidade do Porto Faculdade de Medicina, Portugal |
2018 - 2018 | Evaluator of the Final Report entitled "Reactivity of the mesenteric artery to angiotensin II and hydrogen peroxide in an experimental model of inflammatory bowel disease", developed within the scope of the discipline Project I by the student Melani Adão Sousa, Integrated Master in Pharmaceutical Sciences, FFUP. | Universidade do Porto Faculdade de Farmácia, Portugal |
2017 - 2017 | Jury, Poster session, IJUP 2017 (Meeting of Young Researchers of Universidade do Porto, 2017), FMUP, Porto, Portugal. | Universidade do Porto Faculdade de Medicina, Portugal |
2017 - 2017 | Evaluator of the Final Report entitled "Effect of the perivascular adipose tissue on mesenteric artery response to hydrogen peroxide", developed within the scope of the discipline Project I, by the student Paula Cristina de Jesus Gomes, Integrated Master in Pharmaceutical Sciences, FFUP. | Universidade do Porto Faculdade de Farmácia, Portugal |
2016 - 2016 | Evaluator of the Final Report entitled "Vascular reactivity of the mesenteric artery and vein to vasoconstrictors and vasodilators: influence of gender", developed within the scope of the discipline Project I by the student Marta Sofia Gonçalves da Silva, Integrated Master in Pharmaceutical Sciences, FFUP. | Universidade do Porto Faculdade de Farmácia, Portugal |
2013 - 2013 | President of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the project "Interaction of aspirin with antihypertensive drugs: impact on blood pressure control and oxidative stress, inflammation and activation of the renal renin-angiotensin system" (PTDC/SAU-TOX/114166/2009), funded by FEDER via COMPETE and national funds by FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2013 - 2013 | Member of the jury of the call for the attribution of a Research fellowship (BI) within the scope of the project "Inflammation and vascular injury in childhood obesity" (PTDC/DTP-PIC/0239/2012), funded by FEDER funds via COMPETE and by national funds by the FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2011 - 2011 | Member of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the project "Hypertension and painful neuropathy in diabetes. Role of angiotensin II and oxidative stress in central nervous system" (PTDC/SAU-NEU/101090/2008), funded by FEDER funds via COMPETE and national funds by FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2011 - 2011 | President of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the project "Interaction of aspirin with antihypertensive drugs: impact on blood pressure control and oxidative stress, inflammation and activation of the renal renin-angiotensin system" (PTDC/SAU-TOX/114166/2009), funded by FEDER funds via COMPETE and national funds by FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2009 - 2009 | Member of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the project "Adenosine-angiotensin II interactions and glomerular injury in Diabetes associated with Hypertension: a new target with therapeutic interest?" (PTDC/SAL/FCF-67764 /2006), funded by FEDER funds via COMPETE and national funds by the FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
2009 - 2009 | Evaluator of the Final Report entitled "Isolation and culture of glomerular mesangial cells and their morphological characterization", developed within the scope of the discipline Project I by the student Catarina Alexandra da Silva Chaves, Integrated Master in Pharmaceutical Sciences, FFUP. | Universidade do Porto Faculdade de Farmácia, Portugal |
2007 - 2007 | Member of the jury of the call for the attribution of a Research Fellowship (BI) within the scope of the project "Adenosine-angiotensin II interactions and glomerular injury in Diabetes associated with Hypertension: a new target with therapeutic interest?" (PTDC/SAL/FCF-67764 /2006), funded by FEDER funds via COMPETE and national funds by FCT. | Universidade do Porto Faculdade de Medicina, Portugal |
Distinctions
Award
2024 | Ambiotis Poster Award (9th European Workshop on Lipid Mediators)
Ambiotis, France
|
2023 | Molecular Biology & Physiology Parallel Oral Session First Prize (18th YES Meeting)
Fundação Professor Ernesto Morais, Portugal
|
2020 | ESCI Short Presentation Award (European Society of Clinical Investigation)
European Society of Clinical Investigation, Netherlands
|
2019 | 3rd Prize - Oral Presentation - Plenary Session (14th YES Meeting Scientific Committee)
Fundação AstraZeneca, Portugal
|
2018 | Grant for Young Investigators in Pain -2018 (Fundação Grünenthal)
Fundação Grünenthal, Portugal
|
2015 | Pediatrics Award for studies in other pediatric specialties (Sociedade Portuguesa de Pediatria)
Sociedade Portuguesa de Pediatria, Portugal
|
2013 | Alberto Ferrari Poster Prize (European Society of Hypertension)
European Society of Hypertension, Italy
|
2007 | Young Investigator Prize - Portuguese Society of Hypertension
Sociedade Portuguesa de Hipertensão, Portugal
|
2002 | Lars-Erik Gelin Conference Travel Award (European Society for Microcirculation)
European Society for Microcirculation, United Kingdom
|
2002 | Young Investigator Prize - Gulbenkian Research Stimulus Programme
Fundação Calouste Gulbenkian, Portugal
|
2001 | Poster Award (EPHAR)
3rd Meeting of the Federation of European Pharmacological Societies (EPHAR), France
|